The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NCI-MATCH (Molecular Analysis for Therapy Choice) – a national signal finding trial.
 
Barbara A. Conley
No Relationships to Disclose
 
Alice P. Chen
No Relationships to Disclose
 
Peter J. O'Dwyer
Consulting or Advisory Role - Bristol-Myers Squibb; Five Prime Therapeutics; Forty Seven; Genentech
Research Funding - BBI Healthcare; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Merck; Mirati Therapeutics; Novartis; Pfizer
 
Carlos L. Arteaga
Leadership - American Association for Cancer Research
Stock and Other Ownership Interests - Provista Diagnostics
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; KIYATEC; Lilly; Monogram Biosciences; Novartis; Roche; Seragon; Susan G. Komen for the Cure
Research Funding - AstraZeneca; Novartis; Puma Biotechnology; U3Pharma
 
Stanley R. Hamilton
Consulting or Advisory Role - Amgen; Intervention Insights; Medical Research Council; Palmetto GBA
 
Paul M. Williams
No Relationships to Disclose
 
Richard F. Little
No Relationships to Disclose
 
Naoko Takebe
No Relationships to Disclose
 
David Patton
No Relationships to Disclose
 
Kamalia Sazali
No Relationships to Disclose
 
Jeffrey Zhang
No Relationships to Disclose
 
James A. Zwiebel
No Relationships to Disclose
 
Edith P. Mitchell
Honoraria - Sanofi
Consulting or Advisory Role - Genentech
Research Funding - Genentech (Inst); sanofi (Inst)
 
Robert James Gray
Research Funding - Abbott Molecular; Agios; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Genomic Health; Genzyme; GlaxoSmithKline; ImClone Systems; Janssen-Ortho; Kanisa; Millennium; Nodality; Novartis; Onyx; OSI Pharmaceuticals; Pfizer; Sanofi; Sequenta; Syndax
 
Lisa McShane
No Relationships to Disclose
 
Shuli Li
No Relationships to Disclose
 
Larry Rubinstein
No Relationships to Disclose
 
Keith Flaherty
Leadership - Clovis Oncology; Loxo
Stock and Other Ownership Interests - Clovis Oncology; Loxo
Honoraria - Clovis Oncology; Loxo; Novartis; Roche/Genentech
Consulting or Advisory Role - Novartis; Roche/Genentech